Anemia
News
FDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria
The drug’s novel formulation means that patients can be treated every eight weeks, instead of every two weeks as is the case with the previously...
News
FDA aims to boost safety of platelets for transfusion
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
From the Journals
In-hospital blood saving strategy appears safe with anemia
Tolerating moderate in-hospital anemia did not negatively impact readmissions or mortality over 6 months.
Conference Coverage
Brain injury in sickle cell merits more attention
BETHESDA, MD – It’s time to consider the silent infarcts of sickle cell patients.
Conference Coverage
Despite risks, exercise is important for patients with sickle cell
SAN DIEGO – Consider the benefits of fitness and don’t let all patients with sickle cell stay sedentary.
Video
Sickle cell disease guidelines release set for early 2019
SAN DIEGO – Five new ASH guidelines for sickle cell disease are on the way, likely early in 2019.
Conference Coverage
Opioids appear safe for sickle cell pain
SAN DIEGO – For sickle cell patients, opioid-related mortality is essentially a “never” event.
Video
New treatments promise sickle cell “cure” for all ages
SAN DIEGO – Dr. Ify Osunkwo described the latest approaches, from gene therapy to haploidentical stem cell transplant, as well as patient access...
Conference Coverage
Sickle cell disease phenotype reversed by gene therapy
SAN DIEGO – Genetically modified autologous stem cells increased protective fetal hemoglobin and decreased sickle hemoglobin in an adult with...
Video
Flipping the fetal hemoglobin switch reverses sickle cell symptoms
SAN DIEGO – One adult with sickle cell disease had near-complete remission of symptoms after 6 months of follow-up.
Conference Coverage
Researchers seek more sickle cell drug research
BETHESDA, MD – While there are experimental treatments such as ...